Ország: Ausztria
Nyelv: angol
Forrás: HMA (Heads of Medicines Agencies)
enrofloxacin 100 mg/ml
aniMedica GmbH
QJ01MA90
Solution for injection
enrofloxacin
Cattle Food, Pigs Food
2012-07-25
1 von 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrotron 100, 100 mg/ml solution for injection for cattle and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: ACTIVE SUBSTANCE Enrofloxacin 100.0 mg EXCIPIENTS 1-Butanol 30.0 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. Clear, slightly yellowish to yellowish orange solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle Pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _ _ For the treatment of infectious diseases in cattle and pigs caused by the following enrofloxacin- susceptible gram-negative and gram-positive bacteria and mycoplasma: _ _ CATTLE _: _ - Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. _pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia_) and secondary bacterial infections subsequent to viral conditions (e.g. crowding disease) and acute E. coli mastitis with poor general condition - _E. coli, Haemophilus spp., Pasteurella multocida, Mannheimia haemolytica, Mycoplasma bovis_ PIGS_: _ _ _ - Diseases of the respiratory (enzootic pneumonia, pleuropneumonia) and alimentary tract (colidiarrhoea, colisepticemia) of bacterial or mycoplasmal origin, MMA-syndrome of sows _- E. coli, Pasteurella multocida, Mannheimia haemolytica, Mycoplasma hyopneumoniae, _ _Actinobacillus pleuropneumoniae _ _ _ Enrofloxacin should be used where clinical experience, supported where possible by susceptibility testing of the causal organism, indicates enrofloxacin as the drug of choice. Olvassa el a teljes dokumentumot